The Dimensions of a Qualified Candidate, Part 3:

The Dimensions of a Qualified Candidate, Part 3:

The Dimensions of a Qualified Candidate, Part 3:

When you’ve determined that you have a qualified candidate: you know why he wants to leave his current company, that he has valid reasons for exploring your opportunity, and that you can provide what’s important to him, you have two important but too-often neglected tasks:

Read More

The Dimensions of a Qualified Candidate, Part 2:

The Dimensions of a Qualified Candidate, Part 2:

The Dimensions of a Qualified Candidate, Part 2:

Four Strategies for Getting the Information You Need

Read More

Collective Medical Names Steven Goldschmidt VP of Post-Acute Business Development

Collective Medical Names Steven Goldschmidt VP of Post-Acute Business Development

Collective Medical Names Steven Goldschmidt VP of Post-Acute Business Development

SALT LAKE CITY - May 22, 2018 - Steven Goldschmidt joins Collective Medical Technologies as VP of Post-Acute Business Development. 

Read More

The Dimensions of a Qualified Candidate, Part 1:

The Dimensions of a Qualified Candidate, Part 1:

The Dimensions of a Qualified Candidate, Part 1:

If I were to ask you, “What is a qualified candidate?” what would your answer be?

Read More

Healthify Names Cesar Herrera VP of Client Services

Healthify Names Cesar Herrera VP of Client Services

Healthify Names Cesar Herrera VP of Client Services

February 26, 2018 - Cesar Herrera has joined Healthify as the new VP of Client Services. 
Cesar joins Healthify from ZocDoc where he was Head of Existing Business for Enterprise. He was responsible for overall retention and growth with Health Systems, in addition to leading product commercialization efforts with existing customers.

Read More

Healthify Names Jim Devlin VP of Sales

Healthify Names Jim Devlin VP of Sales

Healthify Names Jim Devlin VP of Sales

January 18, 2018- Jim Devlin has joined Healthify as the new VP of Sales. Jim is a high performing sales leader, responsible for direct sales of more than $250 million in revenue throughout the course of his career. Prior to joining Healthify Jim was the Area Vice President of the Phytel Business Unit at IBM Watson Health where he oversaw ...

Read More

Lucina Health Names Clint Reid Chief Revenue Officer

Lucina Health Names Clint Reid Chief Revenue Officer

Lucina Health Names Clint Reid Chief Revenue Officer

September 29, 2017 - Clint Reid has joined Lucina Health as the new Chief Revenue OfficerClint has an extensive 15+ years of Sales and Business Development Leadership experience in Health IT and Insurance. Prior to joining Lucina Clint was the EVP Sales at Altruista Health where he played a vital role in their 3 year growth from $2M to $23M. Clint has also had successful Sales Leadership stints with Medecision, United Healthcare and CIGNA.

Read More

Amplion Names Sherry Henricks as VP of Sales.

Amplion Names Sherry Henricks as VP of Sales.

Amplion Names Sherry Henricks as VP of Sales.

September 12, 2017 - Sherry Henricks has joined Amplion Clinical Communications as the VP of Sales. Prior to Amplion, Sherry was the SVP of Sales at Extension Healthcare and lead the company’s Sales and Business Development efforts through their acquisition by Vocera. Sherry’s prior experience includes Network Development & Strategy with LifeBridge Health as well as Sales & Business Development Leadership with Emergin (acquired by Philips Healthcare), Draeger and Siemens Medical.  

Read More
     

  

    
       
      
         
          
             
                  
             
          

          

         
      
       
    

  


     The 6 Hottest Startups in Health Care  Original article found  here .   Health care  presents one of the biggest opportunities for startups--as well as some of the biggest frustrations. The market size and the potential to make an impact in people's lives are nearly unrivaled, as is the level of regulation. Still, in 2016, venture investors poured  $12.2 billion into health care , backing companies that promise to change everything from  cancer care  to the process of  finding a new doctor . Here are some of the standouts.  1. Flatiron Health  Google Ventures-backed Flatiron Health has developed a cloud-based technology platform that's currently used by about 260 cancer clinics. The New York City startup takes the patient data it collects from those centers--without identifying details, of course--and shares it with pharmaceutical companies and researchers. The company raised an $8 million series A round in 2013. A little more than a year later, it raised $130 million, and a year after that, an additional $175 million, bringing its valuation to about $1.2 billion. Flatiron is one of fewer than a dozen billion-dollar-valuation "unicorn" companies in the health care space.  Major Investors: Google Ventures, First Round Capital, Roche, Allen & Co.   2. Freenome   Freenome, headquartered in South San Francisco, is one of a slew of so-called liquid biopsy (i.e., blood test) companies to break out over the past few years. The goal is to use a patient's DNA, rather than a tissue sample, to diagnose cancer. Freenome says its tests do better than the current options for diagnosing prostate, breast, colorectal, and lung cancers. The company is using a $65 million round of funding, led by Andreessen Horowitz, to head into clinical trials.  Major investors: Andreessen Horowitz, Founders Fund, Charles River Associates   3. Clover Health   Another health care unicorn, Clover Health is an insurance start-up aiming to use data science to improve preventive medicine. The San Francisco-based company tracks dozens of clinical and social data points to help elderly and low-income patients avoid hospital visits. It currently handles claims for about 25,000 Medicare Advantage patients in New Jersey. With a recent $130 million funding round from Google Ventures and other backers, Clover plans to expand, and begin operations in three more states by this fall.  Major investors: First Round Capital, Sequoia Capital, Greenoaks Capital   4. Zocdoc   New York City-based Zocdoc allows users to find in-network health care providers, book appointments online, and read reviews from other patients. About 6 million patients in the U.S. use the service each month. Providers pay a subscription fee to be listed, and then Zocdoc integrates with their practice management software. Zocdoc recently added a feature that lets patients type in their symptoms using natural language and then matches them with an appropriate provider, such as a doctor, dentist, nurse practitioner, or physical therapist. The company has raised a total of $223 million.  Major investors: Amazon founder Jeff Bezos, Khosla Ventures, Goldman Sachs   5. 23andMe   In 2013, the FDA ruled that genetic-testing company 23andMe, which has raised a total of $233 million, could no longer sell one of its signature services: test results that indicate a person's propensity to develop inherited diseases. Since then, Mountain View, California's 23andMe has mainly been using its genetic testing services to provide information about ancestry and origin. But in April of this year, the company finally won FDA approval to sell direct-to-consumer tests that provide genetic health risk information for conditions such as Parkinson's, Alzheimer's, and hereditary thrombophilia.  Major investors: Google Ventures, New Enterprise Associates, WuXi Healthcare Ventures   6. Babylon Health   London-based Babylon Health, which has raised a total of $85 million, started as a telemedicine company, enabling doctors to make diagnoses via video and allowing patients to rate the quality of each interaction. But it's received more notice lately for another program it's piloting in the U.K.: an AI-powered chatbot that analyzes a patient's condition against a database of symptoms, while incorporating the patient's own medical history and responses to the chatbot's questions.  Major investors: Vostok New Ventures, Hoxton Ventures, Mustafa Suleyman

The 6 Hottest Startups in Health Care

Health care presents one of the biggest opportunities for startups--as well as some of the biggest frustrations. The market size and the potential to make an impact in people's lives are nearly unrivaled, as is the level of regulation.

Read More

Apervita Names David Shreiner as Senior Vice President of Sales

Apervita Names David Shreiner as Senior Vice President of Sales

Apervita Names David Shreiner as Senior Vice President of Sales

March 15, 2017 - David Shreiner joined Apervita in March of 2017 with over 10 years of leadership and sales experience. Prior to joining Apervita, David was the Vice President of Sales at Imprivata. He also served as VP of Sales and National VP of Sales at Carefusion.

David received his undergraduate degree from Miami University in Business, Marketing/Economics.

Read More